-
VER 155008: Dissecting Hsp70 Inhibition in Liquid-Liquid ...
2025-09-27
Discover the unique role of VER 155008, a potent adenosine-derived HSP 70 inhibitor, in modulating both heat shock protein signaling and liquid-liquid phase separation. This article unveils advanced mechanistic insights and experimental applications, setting a new benchmark for cancer research and apoptosis assays.
-
2025-09-26
Discover how SR-202, a selective PPAR antagonist, enables advanced research into adipocyte plasticity and the immune-metabolic interface. This article uniquely explores SR-202's applications in dissecting PPAR signaling and innovating anti-obesity and type 2 diabetes research.
-
Pseudo-modified Uridine Triphosphate: Redefining mRNA Syn...
2025-09-25
Explore how Pseudo-modified uridine triphosphate (Pseudo-UTP) revolutionizes mRNA synthesis with pseudouridine modification, enabling next-generation vaccine development and RNA therapeutics. Discover unique insights into OMV-based delivery and future directions for personalized medicine.
-
Adenosine Triphosphate (ATP): Decoding Post-Translational...
2025-09-24
Explore the evolving landscape of Adenosine Triphosphate (ATP) in mitochondrial metabolism, focusing on its pivotal role in post-translational enzyme regulation and metabolic pathway investigation. This cornerstone article synthesizes new research insights, offering an advanced perspective beyond traditional views of ATP as a universal energy carrier.
-
Gastrin I (human): Advancing Intestinal Organoid and CCK2...
2025-09-23
Explore the pivotal role of Gastrin I (human) as a gastric acid secretion regulator and CCK2 receptor agonist in next-generation gastrointestinal physiology studies, with a focus on its applications in intestinal organoid models and receptor-mediated signal transduction.
-
L1023 Anti-Cancer Compound Library: Empowering Target Dis...
2025-09-22
Explore how the L1023 Anti-Cancer Compound Library accelerates drug discovery for clear cell renal cell carcinoma (ccRCC) and other malignancies by enabling high-throughput screening of potent, cell-permeable anti-cancer agents targeting critical pathways such as BRAF kinase, EZH2, and mTOR.
-
eukaryotic translation initiation factor 3
2025-09-19
-
Plerixafor (AMD3100) in Translational Research: Mechanism...
2025-09-19
Explore the multifaceted research applications of Plerixafor (AMD3100), a potent CXCR4 chemokine receptor antagonist, with a focus on its mechanistic role in hematopoietic stem cell and neutrophil mobilization, cancer metastasis inhibition, and emerging directions beyond oncology.
-
Anti-mTOR Rabbit Polyclonal Antibody
2025-09-19
-
WY-14643 (Pirinixic Acid): A Selective PPARα Agonist Shap...
2025-09-18
This article examines WY-14643 (Pirinixic Acid) as a potent and selective PPARα agonist, highlighting its applications in metabolic disorder research and its roles in lipid metabolism regulation and TNF-α mediated inflammation. Recent findings in cancer biology and inflammation are contextualized to inform experimental design and mechanistic studies.
-
GSK963
2025-09-18
-
Cefotetan
2025-09-18
-
GNE-064
2025-09-17
-
Anti-GRP78 BiP Rabbit Polyclonal Antibody
2025-09-17
-
ANP (1-11), rat
2025-09-16